224
Views
3
CrossRef citations to date
0
Altmetric
Articles

Coagulation disorders and inhibitors of coagulation in children from Mansoura, Egypt

, , &
Pages 309-314 | Published online: 04 Sep 2013

References

  • Kurnik K. Blood coagulation disorders in children. Hamos-taseologie 2004;24 (2): 116–122.
  • Sevier N. Inherited coagulation factor abnormalities: A pediatric review. J Pediatr Oncol Nurs 2005;22 (3):137–144.
  • Bolton-Maggs PH. Optimal haemophilia care versus the reality. Br J Haematol 2006;132(6):671–682.
  • Carnelli V, Dozzi M, Gibelli M, Giovanniello A, Riva F, Seidita C, Stucchi C. Children with hemorrhagic diathesis: Correct diagnostic and therapeutic approach. Pediatr Med Chir 1990; 12(1):1–13.
  • Renella R, Nenadov-Beck M, Vienny H, Gehri M. My child bleeds easily: Clinical and paraclinical approach. Rev Med Suisse Romande 2002;122(12):599–601.
  • Islam SI, Quadri MI. Spectrum of hereditary coagulation factor deficiencies in eastern province, Saudi Arabia. East Mediterr Health J November 1999;5 (6) :1188–1195.
  • Manno CS. Management of bleeding disorders in children. Hematology Am Soc Hematol Educ Program 2005;:416–422.
  • Hafez M, El-Tahan H, Awadalla M, El-Khayat H, Abdel-Gafar A, Ghoneim M. Consanguineous matings in the Egyptian population. J Med Genet 1983;20(1):58–60.
  • Mannucci PM. Hemophilia and related bleeding disorders: A story of dismay and success. Hematology Am Soc Hematol Educ Program 2002;:1–9.
  • Goldstein DB, Reich DE, Bradman N, Usher S, Seligsohn U, Peretz H. Age estimates of two common mutations causing factor XI deficiency: Recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews. Am J Hum Genet A 1999;64(4):1071–1075.
  • Lee SS, Wong KH, Dickinson AJ. Haemophilia and HIV infection in Hong Kong. AIDS Care 1996;8(3):365–372.
  • Jayandharan GR, Viswabandya A, Baidya S, Nair SC, George B, Mathews V, Chandy M, Srivastava A. Mutations in coagulation factor XIII A gene in eight unrelated Indians. Five novel mutations identified by a novel PCR-CSGE approach. Thromb Haemost March 2006;95(3):551–556.
  • Srivastava A. Optimizing clotting factor replacement therapy in hemophilia: A global need. Hematology 2005;10(Suppl 1): 229–230.
  • Srivastava A, Rodeghiero F. Epidemiology of von Willebrand disease in developing countries. Semin Thromb Hemost 2005; 31(5):569–576.
  • Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed 2004;89(6):F475—F478.
  • Windyga J, Lopaciuk S, Stefanska E, Juszynski A, Wozniak D, Strzelecki O, Szczepanik AB. Haemophilia in Poland. Haemophilia 2006;12(1):52–57.
  • Aledort LM, Green D, Teitel JM. Unexpected bleeding disorders. Hematology Am Soc Hematol Educ Program 2001; 306–321.
  • Martlew VJ. Pen-operative management of patients with coagulation disorders. Br J Anaesth 2000;85(3):446–455.
  • Peyvandi F. Carrier detection and prenatal diagnosis of hemophilia in developing countries. Semin Thromb Hemost 2005;31 (5):544–554.
  • Shetty S, Ghosh K, Mohanty D. Alternate strategies for carrier detection and antenatal diagnosis in haemophilias in develop-ing countries. Ind J Hum Genet 2003;9(1):5–9.
  • Wight J, Paisley S, Knight C. Immune tolerance induction in patients with haemophilia A with inhibitors: A systematic review. Haemophilia 2003;9:436–463.
  • Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, Shapiro A, Scheibel E, White G, III, Lee M. A multicenter study of recombinant factor VIII (recombinate): Safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group. Blood 1994;83:2428–2435.
  • Oldenburg J, El-Maarri O, Schwaab R. Inhibitor development in correlation to factor VIII genotypes. Haemophilia 2002; 8\(Suppl. 2):23–29.
  • Goodeve AC, Peake IR. The molecular basis of hemophilia A: Genotype-phenotype relationships and inhibitor development. Semin Thromb Hemost 2003;29:23–30.
  • Astermark J, Berntorp E, White GC, Kroner BL. The Malmo International Brother Study (MIBS): Further support for genetic predisposition to inhibitor development in hemophilia patients. Haemophilia 2001;7:267–272.
  • Dimichele D, Rivard G, Hay C, Antunes S. Inhibitors in haemophilia: Clinical aspects. Haemophilia 2004;10(Suppl 4): 140–145.
  • Kimbrell JD. Acquired coagulopathies. Crit Care Nurs Clin North Am 1993;5(3):453–458.
  • Sutor AH. New aspects of vitamin K prophylaxis. Semin Thromb Hemost 2003;29(4):373–376.
  • von Kries R, Hanawa Y. Neonatal vitamin K prophylaxix. Report of Scientific and Standardization Subcommittee on Perinatal Haemostasis. Thromb Haemost 1993;69(3): 293–295.
  • Autret-Leca E, Jonville-Bera AP. Vitamin K in neonates: How to administer, when and to whom. Paediatr Drugs 2001;3(1): 1–8.
  • Bay A, Oner AF, Kose D, Dogan M. Global fibrinolytic capacity in pediatric patients with sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2006; 17(7):569–573.
  • Oren H, Cingoz I, Duman M, Yilmaz S, Irken G. Disseminated intravascular coagulation in pediatric patients: Clinical and laboratory features and prognostic factors influencing the survival. Pediatr Hematol Oncol 2005;22(8): 679–688.
  • Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis 2002; 22(1):83–96.
  • Omran SA, el-Bassiouni NE, Hussein NA, Akl MM, Hussein AT, Mohamed AA. Disseminated intravascular coagulation in endemic hepatosplenic schistosomiasis. Haemostasis 1995; 25(5):218–228.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.